دورية أكاديمية

Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group

التفاصيل البيبلوغرافية
العنوان: Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group
المؤلفون: K. I. Sapova, S. V. Ryazantsev
المصدر: Медицинский совет, Vol 0, Iss 20, Pp 107-110 (2018)
بيانات النشر: Remedium Group LLC, 2018.
سنة النشر: 2018
المجموعة: LCC:Medicine
مصطلحات موضوعية: persistent (perennial) allergic rhinitis, patients of the older age group, combination drug, spray momate rhino advance, Medicine
الوصف: Recent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined. This article describes the persistent allergic rhinitis in patients of the older age group and identifies the primary goals of treatment based on the age-related physiological factors, concomitant conditions and the use of other drugs. Special attention is paid to the various options for the drug therapy in elderly patients over the age of 60 years. The second-generation antihistamines and intranasal glucocorticosteroids also have primacy over other drugs, when supervising older patients. A randomized open multicenter clinical study showed that Momate Rhino Advance (a combination of intranasal antihistamines (azelastine) and intranasal glucocorticosteroids (mometasone) for the treatment of allergic rhinitis) made by Indian Glenmark Pharmaceuticals Ltd. is effective and safe in patients aged 60 years and older, who are diagnosed with the above disease.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: Russian
تدمد: 2079-701X
2658-5790
Relation: https://www.med-sovet.pro/jour/article/view/2783; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790
DOI: 10.21518/2079-701X-2018-20-107-110
URL الوصول: https://doaj.org/article/688649453f45402db4d8eb40015e0d2e
رقم الأكسشن: edsdoj.688649453f45402db4d8eb40015e0d2e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2079701X
26585790
DOI:10.21518/2079-701X-2018-20-107-110